日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma.

贝伐珠单抗和厄洛替尼在肾髓质癌和富马酸水合酶缺乏型肾细胞癌临床前模型中的差异疗效

Zacharias Niki M, Ozambela Manuel, Karki Menuka, He Rong, Chauhan Pankaj K, Pesquera Pedro I, Hernandez Gonzalez Andres E, Ochoa Oscar, Pieretti Alberto, Chen Huiqin, De La Cerda Carolyn, Yu Zhiyuan, Grover Abha, Hicks-Peña Samantha, Fowlkes Natalie W, Wang Lei, Maity Tapati, Rao Priya, Genovese Giannicola, Tannir Nizar M, Karam Jose A, Msaouel Pavlos

Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell Tumor

睾丸生殖细胞肿瘤病史患者后续恶性肿瘤的起源

Umbreit, Eric C; Siddiqui, Bilal A; Hwang, Michael J; Joon, Aron Y; Maity, Tapati; Westerman, Mary E; Merriman, Kelly W; Alhasson, Hussam; Uthup, Joma; Guo, Tao; Moore, Joseph A; Ward, John F; Karam, Jose A; Wood, Christopher G; Pisters, Louis L; Zhang, Miao; Tu, Shi-Ming

Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma

局部晚期非转移性透明细胞肾细胞癌患者新辅助阿昔替尼治疗的II期临床试验

Karam, Jose A; Devine, Catherine E; Urbauer, Diana L; Lozano, Marisa; Maity, Tapati; Ahrar, Kamran; Tamboli, Pheroze; Tannir, Nizar M; Wood, Christopher G

Type III transforming growth factor-beta (TGF-beta) receptor mediates apoptosis in renal cell carcinoma independent of the canonical TGF-beta signaling pathway

III型转化生长因子-β(TGF-β)受体介导肾细胞癌的细胞凋亡,且该过程独立于经典的TGF-β信号通路。

Margulis, Vitaly; Maity, Tapati; Zhang, Xiu-Ying; Cooper, Simon J; Copland, John A; Wood, Christopher G